Correction to: Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis. . Inflamm Bowel Dis 2025 Jul 1:izaf140. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis. Inflamm Bowel Dis 2025 Jul 1:izaf140. doi: 10.1093.
PMID: 40591419